810 related articles for article (PubMed ID: 20136495)
21. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
[TBL] [Abstract][Full Text] [Related]
22. Non-destructive methods of characterization of risperidone solid lipid nanoparticles.
Rahman Z; Zidan AS; Khan MA
Eur J Pharm Biopharm; 2010 Sep; 76(1):127-37. PubMed ID: 20470882
[TBL] [Abstract][Full Text] [Related]
23. Novel solid lipid nanoparticles as carriers for oral administration of insulin.
Zhang Z; Lv H; Zhou J
Pharmazie; 2009 Sep; 64(9):574-8. PubMed ID: 19827297
[TBL] [Abstract][Full Text] [Related]
24. Poly(vinyl alcohol) as emulsifier stabilizes solid triglyceride drug carrier nanoparticles in the alpha-modification.
Rosenblatt KM; Bunjes H
Mol Pharm; 2009; 6(1):105-20. PubMed ID: 19049318
[TBL] [Abstract][Full Text] [Related]
25. Preparation, characterization, and anti-tumor property of podophyllotoxin-loaded solid lipid nanoparticles.
Zhu RR; Qin LL; Wang M; Wu SM; Wang SL; Zhang R; Liu ZX; Sun XY; Yao SD
Nanotechnology; 2009 Feb; 20(5):055702. PubMed ID: 19417361
[TBL] [Abstract][Full Text] [Related]
26. Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery.
Dhawan S; Kapil R; Singh B
J Pharm Pharmacol; 2011 Mar; 63(3):342-51. PubMed ID: 21749381
[TBL] [Abstract][Full Text] [Related]
27. Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection.
Wang JJ; Liu KS; Sung KC; Tsai CY; Fang JY
Eur J Pharm Sci; 2009 Sep; 38(2):138-46. PubMed ID: 19591929
[TBL] [Abstract][Full Text] [Related]
28. Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil.
Zhao XL; Yang CR; Yang KL; Li KX; Hu HY; Chen DW
Drug Dev Ind Pharm; 2010 Jul; 36(7):773-80. PubMed ID: 20136496
[TBL] [Abstract][Full Text] [Related]
29. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles.
Vivek K; Reddy H; Murthy RS
AAPS PharmSciTech; 2007 Oct; 8(4):E83. PubMed ID: 18181544
[TBL] [Abstract][Full Text] [Related]
30. Development and optimization of baicalin-loaded solid lipid nanoparticles prepared by coacervation method using central composite design.
Hao J; Wang F; Wang X; Zhang D; Bi Y; Gao Y; Zhao X; Zhang Q
Eur J Pharm Sci; 2012 Sep; 47(2):497-505. PubMed ID: 22820033
[TBL] [Abstract][Full Text] [Related]
31. Development and evaluation of coenzyme Q10 loaded solid lipid nanoparticle hydrogel for enhanced dermal delivery.
Korkm E; Gokce EH; Ozer O
Acta Pharm; 2013 Dec; 63(4):517-29. PubMed ID: 24451076
[TBL] [Abstract][Full Text] [Related]
32. Characterization and in vitro assessment of paclitaxel loaded lipid nanoparticles formulated using modified solvent injection technique.
Pandita D; Ahuja A; Velpandian T; Lather V; Dutta T; Khar RK
Pharmazie; 2009 May; 64(5):301-10. PubMed ID: 19530440
[TBL] [Abstract][Full Text] [Related]
33. Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: characterization and ability to bind the pEGFP-plasmid.
Vighi E; Ruozi B; Montanari M; Battini R; Leo E
Eur J Pharm Biopharm; 2007 Sep; 67(2):320-8. PubMed ID: 17368876
[TBL] [Abstract][Full Text] [Related]
34. Differential scanning calorimetry studies on sunscreen loaded solid lipid nanoparticles prepared by the phase inversion temperature method.
Montenegro L; Sarpietro MG; Ottimo S; Puglisi G; Castelli F
Int J Pharm; 2011 Aug; 415(1-2):301-6. PubMed ID: 21679757
[TBL] [Abstract][Full Text] [Related]
35. [Optimization preparation of chansu-loaded solid lipid nanoparticles by central composite design and response surface method].
Yang Y; Feng JF; Zhang H; Luo JY
Zhongguo Zhong Yao Za Zhi; 2006 Apr; 31(8):650-3. PubMed ID: 16830822
[TBL] [Abstract][Full Text] [Related]
36. Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications.
Araújo J; Gonzalez-Mira E; Egea MA; Garcia ML; Souto EB
Int J Pharm; 2010 Jun; 393(1-2):167-75. PubMed ID: 20362042
[TBL] [Abstract][Full Text] [Related]
37. [Preparation of tetrandrine solid lipid nanoparticles].
Li YC; Dong L; Jia A; Chang XM; Xue H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Oct; 28(5):686-9. PubMed ID: 17121232
[TBL] [Abstract][Full Text] [Related]
38. Improvement of digoxin oral absorption in rabbits by incorporation into solid lipid nanoparticles.
Hu L; Jia H; Luo Z; Liu C; Xing Q
Pharmazie; 2010 Feb; 65(2):110-3. PubMed ID: 20225654
[TBL] [Abstract][Full Text] [Related]
39. Role of Isradipine Loaded Solid Lipid Nanoparticles on the Pharmacodynamic Effect in Rats.
Thirupathi G; Swetha E; Narendar D
Drug Res (Stuttg); 2017 Mar; 67(3):163-169. PubMed ID: 27992936
[TBL] [Abstract][Full Text] [Related]
40. Preparation and in vitro, in vivo evaluations of norfloxacin-loaded solid lipid nanopartices for oral delivery.
Dong Z; Xie S; Zhu L; Wang Y; Wang X; Zhou W
Drug Deliv; 2011 Aug; 18(6):441-50. PubMed ID: 21554156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
